ArticlePloS one2018

Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

Takuma Matsumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.